Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 448

1.

EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.

Schmidt R, Redecke V, Breitfeld Y, Wantia N, Miethke T, Massberg S, Fischel S, Neumann FJ, Schömig A, May AE.

Thromb Haemost. 2006 Jan;95(1):151-8.

PMID:
16543974
2.

Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.

Schmidt R, Bültmann A, Ungerer M, Joghetaei N, Bülbül O, Thieme S, Chavakis T, Toole BP, Gawaz M, Schömig A, May AE.

Circulation. 2006 Feb 14;113(6):834-41. Epub 2006 Feb 6.

PMID:
16461815
3.

Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.

Schmidt R, Bültmann A, Fischel S, Gillitzer A, Cullen P, Walch A, Jost P, Ungerer M, Tolley ND, Lindemann S, Gawaz M, Schömig A, May AE.

Circ Res. 2008 Feb 15;102(3):302-9. Epub 2007 Nov 29.

PMID:
18048771
6.
7.
8.
9.

Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.

Egawa N, Koshikawa N, Tomari T, Nabeshima K, Isobe T, Seiki M.

J Biol Chem. 2006 Dec 8;281(49):37576-85. Epub 2006 Oct 18.

10.
11.

Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells.

May AE, Schmidt R, Bülbül BO, Hölderle M, Walther F, Schömig A, Gawaz M, Klouche M.

Thromb Haemost. 2005 Apr;93(4):710-5.

PMID:
15841317
12.

Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells.

Haug C, Lenz C, Díaz F, Bachem MG.

Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1823-9. Epub 2004 Aug 19.

PMID:
15319264
13.

Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.

Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.

Am J Hypertens. 2004 Sep;17(9):775-82.

PMID:
15363819
14.
16.

Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages.

Huang Z, Wang L, Meng S, Wang Y, Chen T, Wang C.

Int J Cardiol. 2011 Jan 21;146(2):153-8. doi: 10.1016/j.ijcard.2009.06.023. Epub 2009 Jul 3.

PMID:
19576641
17.

CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.

Zhu P, Lu N, Shi ZG, Zhou J, Wu ZB, Yang Y, Ding J, Chen ZN.

Arthritis Res Ther. 2006;8(2):R44. Epub 2006 Feb 8.

19.

Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma.

Major TC, Liang L, Lu X, Rosebury W, Bocan TM.

Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1200-7.

PMID:
12117738
20.

Extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) as a novel regulator of myogenic cell differentiation.

Attia M, Huet E, Delbé J, Ledoux D, Menashi S, Martelly I.

J Cell Physiol. 2011 Jan;226(1):141-9. doi: 10.1002/jcp.22315. Erratum in: J Cell Physiol. 2011 Mar;226(3):852. Mohamed, Attia [corrected to Attia, Mohamed]; Eric, Huet [corrected to Huet, Eric]; Jean, Delbé [corrected to Delbé, Jean]; Dominique, Ledoux [corrected to Ledoux, Dominique]; Suzanne, Menashi [corrected to Menashi, Suzanne]; Isabelle, Martelly [correcte.

PMID:
20648565

Supplemental Content

Support Center